Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03116113 · ClinicalTrials.gov registry record · Phase 1

A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112

A Phase 1 study of X-Linked Retinitis Pigmentosa, sponsored by Biogen.

Completed
Registry status
Phase 1
Development phase
50
Enrollment target
8
Study locations

NCT03116113 is a Phase 1 study of X-Linked Retinitis Pigmentosa that has completed, run by Biogen. The registered enrollment target is 50 participants, roughly in line with the 52-participant average among 8 other X-Linked Retinitis Pigmentosa trials with a reported enrollment target. The trial reports 8 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03116113, a Phase 1 study of X-Linked Retinitis Pigmentosa, has completed, sponsored by Biogen.

COMPLETED
Registry status
Phase 1
Development phase
50 participants
Enrollment target
8
Study locations

Study Summary

The objective of the study is to evaluate the safety, tolerability and efficacy of a single sub-retinal injection of BIIB112 in participants with X-linked retinitis pigmentosa (XLRP).

Conditions Studied

X-Linked Retinitis Pigmentosa

Interventions

  • BIOLOGICAL BIIB112

Study Locations (8)

Other

  • Research Site - Manchester
  • Research Site - Oxford
  • Research Site - Southampton

Florida

  • Research Site - Gainesville
  • Research Site - Miami

Oregon

  • Research Site - Portland

Pennsylvania

  • Research Site - Philadelphia

Texas

  • Research Site - Dallas

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-03-08
Est. Completion 2020-11-18
Phase Phase 1

Sponsor

Biogen

334 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03116113

The ClinicalTrials.gov registry entry for NCT03116113 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 52-participant average among 8 other X-Linked Retinitis Pigmentosa trials with a reported enrollment target. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with X-Linked Retinitis Pigmentosa appearing as the primary indexed condition, and to 1 intervention - of which BIIB112 is the first listed.

NCT03116113 reports 8 study locations spanning 5 distinct geographic areas - top geographies include Other, Florida, Oregon.

Frequently Asked Questions

What is clinical trial NCT03116113 about?

NCT03116113 is a clinical study titled "A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112". The objective of the study is to evaluate the safety, tolerability and efficacy of a single sub-retinal injection of BIIB112 in participants with X-linked retinitis pigmentosa (XLRP).

What is the current status of trial NCT03116113?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2017-03-08. Estimated completion is 2020-11-18.

What conditions does trial NCT03116113 study?

This clinical trial studies the following conditions: X-Linked Retinitis Pigmentosa.

What interventions are being tested in trial NCT03116113?

The interventions under investigation include: BIIB112 (BIOLOGICAL).

Who is sponsoring clinical trial NCT03116113?

This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03116113 being conducted?

This trial has 8 study locations across Florida, Oregon, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for X-Linked Retinitis Pigmentosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

X-Linked Retinitis Pigmentosa

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.